" class="no-js "lang="en-US"> Seekyo Archives - Medtech Alert
Thursday, May 23, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Seekyo Adds Diagnostics and Theranostics Capabilities to Its Lead Compound SKY01 That Targets Solid Tumors

Seekyo, a startup specializing in developing smart chemotherapy drugs, today announces the availability of personalized […]

Seekyo Reinforces Scientific Advisory Board with Two New Members

Seekyo, a startup company specializing in developing smart chemotherapy drugs, today announces the appointment of two […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more